Search

everythinglearnresearchcommunity

for

Search:↓

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

The treatment was ineffective in humans.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

The drug combination was safe and showed promise in treating advanced tumors.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Stromal Vascular Fraction might help with male sexual dysfunction, but more research is needed to confirm its safety and effectiveness.

In September 2016, there were major advancements and promising clinical trials in stem cell research and regenerative medicine.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

An elderly Chinese man lost all his hair after taking a new heart medication.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Fat-derived stem cell therapies can potentially increase hair growth and thickness in people with hair loss.

Clascoterone is safe for the heart, even at high doses.

Finasteride effectively treats BPH, but needs more trials to understand potential.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

The regenerative medicine industry saw business growth with new partnerships, clinical trials, and financial investments.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Fat tissue stem cells show promise for repairing different body tissues and are being tested in clinical trials.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.